Terminated PHASE4 INTERVENTIONAL 1-arm NCT02767596

Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

A Pilot Single-Arm Open-Label Study to Evaluate the Efficacy of Treatment With Lixisenatide in Diabetes Mellitus Type 2 Patients With Failure of Other GLP-1 Analog

Sponsor: Laniado Hospital

Conditions Diabetes Mellitus Type 2

Interventions Basal insulins Lixisenatide

Updated 6 times since 2017 Last updated: Apr 6, 2017 Started: Jul 12, 2016 Primary completion: Feb 28, 2017 Completion: Feb 21, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient recruitment rate

Other Diabetes Mellitus Type 2 trials with similar outcome

Browse all Diabetes Mellitus Type 2 trials

This PHASE4 trial investigates Diabetes Mellitus Type 2 and is currently terminated or withdrawn. Laniado Hospital leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
May 2017 — Jun 2018 [monthly]

Terminated PHASE4

Status: Not Yet Recruiting → Terminated

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laniado Hospital

Data source: Laniado Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Netanya, Israel